EHS
EHS

MOLOGEN and ONCOLOGIE: Global assignment and co-development agreement relating to MOLOGEN’s lead compound lefitolimod


BERLIN–(BUSINESS WIRE)–MOLOGEN and ONCOLOGIE signed a global assignment and co-development agreement relating to MOLOGEN’s lead compound lefitolimod

Source link

EHS
Back to top button